NCT02152982
Clinical Trial Information
Trial Number: NCT02152982 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Astrocytoma, High Grade
Trial Title:
"A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation"
Study ID:
A071102
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02152982-D3 | Dataset NCT02152982-D3-Dataset.csv (lasa) is one of 3 datasets associated with PubMed ID 39480453. This dataset contains patient reported fatigue data. NCT02152982-D1 contains data presented in the baseline characteristics table and primary and secondary analysis, and NCT02152982-D2 contains adverse event data. |
| NCT02152982-D2 | Dataset NCT02152982-D2-Dataset.csv (adverse_events) is one of 3 datasets associated with PubMed ID 39480453. This dataset contains adverse event data. NCT02152982-D1 contains data presented in the baseline characteristics table and primary and secondary analysis, and NCT02152982-D3 contains patient reported fatigue data. |
| NCT02152982-D1 | Dataset NCT02152982-D1-Dataset.csv (patient) is one of 3 datasets associated with PubMed ID 39480453. This dataset contains data presented in the baseline characteristics table, primary and secondary analysis. NCT02152982-D2 contains adverse event data and NCT02152982-D3 contains patient reported fatigue data. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®